EirGen Pharma anti-cancer product Eir-051 successfully completes clinical trial

EirGen Pharma are pleased to announce that their oncology molecule "Eir-051" has successfully completed clinical studies in February 2008.

EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets